MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
-$887K
Free Cash flow
-$887K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Prepaid expenses and other curre...
Other receivable
Change in fair value of continge...
Depreciation and amortization
Negative Cash Flow Breakdown
Accounts payable
Accrued expenses
Loss from sale or disposal of pr...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
-1,121
-1,828
-2,898
-2,437
Depreciation and amortization
40
49
28
82
Equity-based compensation
0
-
1
0
Right-of-use asset impairment loss
-
-
0
-
Amortization of right-of-use asset
0
57
129
-15
Change in fair value of contingent consideration
52
188
1,012
246
Gain on early lease termination
0
0
0
0
Gain on settlement of accounts payables
0
0
0
155
Loss on disposal/sale of subsidiary
-
-
-98
-
Loss from sale or disposal of property and equipment
9
-37
0
-4
Income tax benefit
-
-
-634
-
Accounts receivable
-
-
-1,342
-
Other receivable
-52
1,459
-
-23
Prepaid expenses and other current assets
-378
-2
3
127
Other noncurrent assets
0
-
-853
-79
Accounts payable
-260
755
404
-530
Accrued expenses
-19
-400
-22
-698
Other liabilities
-
-
0
0
Net cash used in operating activities
-887
-1,142
-1,147
-3,528
Property and equipment
0
-
-213
-106
Proceeds from sale of fixed assets
0
-
0
2
Acquisition of gpcr therapeutics usa inc
-
-
2,090
-
Proceeds from sale of subsidiary
-
-
474
-
Cash removed from the sale of kcc
-
-
232
-
Acquisition of gpcr therapeutics usa inc
0
-2,090
-
0
Net cash used in investing activities
0
0
455
108
Proceeds from short term debt
-
-
0
0
Proceeds from common stock offering
0
0
0
0
Net cash provided by provided by financing activities
0
0
0
0
Net decrease in cash and cash equivalents
-887
-1,142
-692
-3,420
Cash and cash equivalents - beginning of period
2,604
3,746
4,438
12,508
Cash and cash equivalents - end of period
1,717
2,604
3,746
4,438
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
XCUR Cash Flow Sankey Diagram
Sankey diagram visualizing XCUR cash flow for the period
Net decrease in cash
and cash...
-$887K
(80.92%↑ Y/Y)
Prepaid expenses and
other current assets
-$378K
(-123.67%↓ Y/Y)
Other receivable
-$52K
(96.37%↑ Y/Y)
Change in fair value of
contingent consideration
$52K
(-82.37%↓ Y/Y)
Depreciation and
amortization
$40K
(-69.70%↓ Y/Y)
Net cash used in
operating activities
-$887K
(77.14%↑ Y/Y)
Canceled cashflow
$522K
Net income (loss)
-$1,121K
(-388.17%↓ Y/Y)
Accounts payable
-$260K
(-185.81%↓ Y/Y)
Accrued expenses
-$19K
(-117.92%↓ Y/Y)
Loss from sale or
disposal of property and...
$9K
(110.47%↑ Y/Y)
Buy us a coffee
EXICURE, INC. (XCUR)
EXICURE, INC. (XCUR)